1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Digital Therapeutics Market– By Application

1.3.2        Digital Therapeutics Market– By Distribution Channel

1.3.3        Digital Therapeutics Market– By Country

2.           Digital Therapeutics Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Digital Therapeutics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America: PEST Analysis

4.3         Expert Opinion

5.           Digital Therapeutics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Diseases

5.1.2        Concerns Regarding Need to Reduce Healthcare Costs

5.1.3        Partnerships and Collaborations by Companies

5.2         Market Restraints

5.2.1        Cyber Threat and Rise in Data Security

5.3         Market Opportunities

5.3.1        Large Population with Undiagnosed Conditions

5.4         Future Trends

5.4.1        Increasing Number of Start-Ups

5.5         Impact analysis

6.           North America Digital Therapeutics Market Analysis

6.1         North America Digital Therapeutics Market Revenue Forecast and Analysis

7.           Digital Therapeutics Market Analysis – By Application

7.1         Overview

7.2         Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)

7.3         Diabetes

7.3.1        Overview

7.3.2        Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

7.3.3        Cardiovascular Disease

7.3.3.1          Overview

7.3.3.2          Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

7.3.4        Central Nervous System Diseases

7.3.4.1          Overview

7.3.4.2          Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

7.3.5        Respiratory Diseases

7.3.5.1          Overview

7.3.5.2          Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

7.3.6        Smoking Cessation

7.3.6.1          Overview

7.3.6.2          Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

7.3.7        Musculoskeletal Disorders

7.3.7.1          Overview

7.3.7.2          Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

7.3.8        Others

7.3.8.1          Overview

7.3.8.2          Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

8.           Digital Therapeutics Market Analysis – By Distribution Channel

8.1         Overview

8.2         Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)

8.3         Patients

8.3.1        Overview

8.3.2        Patients: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Providers

8.4.1        Overview

8.4.2        Providers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Payers

8.5.1        Overview

8.5.2        Payers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

8.6         Employers

8.6.1        Overview

8.6.2        Employers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

9.           Digital Therapeutics Market–Country Analysis

9.1         North America: Digital Therapeutics Market

9.1.1        Overview

9.1.2        North America: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3        North America: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)

9.1.4        North America: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)

9.1.5        North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)

9.1.5.1          US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1          Overview

9.1.5.1.2          US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3          US: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)

9.1.5.1.4          US: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)

9.1.5.2          Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1          Overview

9.1.5.2.2          Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3          anada: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)

9.1.5.2.4          Canada: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)

9.1.5.3          Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1          Overview

9.1.5.3.2          Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3          Mexico: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)

9.1.5.3.4          Mexico: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.        Impact of COVID-19 Pandemic on North America Digital Therapeutics Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Digital Therapeutics Market –Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Propeller Health (ResMed)

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Canary Health

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Noom, Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      2Morrow, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Teladoc Health, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Welldoc, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Fitbit, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Omada Health, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      MANGO HEALTH

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Pear Therapeutics, Inc.

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

12.11   Happify Health

12.11.1  Key Facts

12.11.2  Business Description

12.11.3  Products and Services

12.11.4  Financial Overview

12.11.5  SWOT Analysis

12.11.6  Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Proportion Of People Living With Undiagnosed Diabetes (20–79 years) Per Region, 2021

Table 2.             North America Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             North America Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 4.             US Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Recent Inorganic Growth Strategies in the Digital Therapeutics Market

Table 11.          Recent Organic Growth Strategies in the Digital Therapeutics Market

Table 12.          Glossary of Terms, Digital Therapeutics Market

LIST OF FIGURES

Figure 1.           Digital Therapeutics Market Segmentation

Figure 2.           Digital Therapeutics Market– By Country

Figure 3.           Digital Therapeutics Market Overview

Figure 4.           Diabetes Segment Held Largest Share of Digital Therapeutics Market by Application

Figure 5.           North America Digital Therapeutics Market– Leading Country Markets (US$ Million)

Figure 6.           North America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Digital Therapeutics market impact analysis of driver and restraints

Figure 9.           North America Digital Therapeutics Market – Revenue Forecast and Analysis – 2021 - 2028

Figure 10.        Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)

Figure 11.        Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)

Figure 19.        Patients: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Providers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Payers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Employers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America: Digital Therapeutics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 24.        North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)

Figure 26.        US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Impact of COVID-19 Pandemic in North American Country Markets